XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Deficit)
6 Months Ended
Jun. 30, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Equity (Deficit) Stockholders’ Equity (Deficit)
Preferred Stock
The Company is authorized to issue up to 49,995,966 shares of preferred stock. As of June 30, 2020 and December 31, 2019, there were 175.53 and 105.33 shares issued and outstanding, respectively. The outstanding shares of preferred stock as of June 30, 2020 and December 31, 2019 are classified as debt. See Note 5. Debt and Note 11. Subsequent Events for additional information about the Redeemable Preferred Stock.
Common Stock
The Company is authorized to issue up to 500,000,000 shares of common stock. As of June 30, 2020 and December 31, 2019, the issued and outstanding shares were 140,325,114 and 139,060,180, respectively.
The following table presents common stock activity for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30,
20202019
Common stock outstanding, beginning of period139,060,180 98,292,530 
Shares issued for acquisition of iPass— 9,865,412 
Shares issued for acquisition of Devicescape— 400,000 
Warrant exercises— 858,344 
Shares issued for conversion of note— 84,220 
Shares issued in connection with debt facility— 425,000 
Shares issued for settlement of accounts payable/debt— 786,246 
Shares issued for exercised stock options— 176,177 
Vesting of restricted and common stock awards1,264,934 1,506,420 
Common stock outstanding, end of period140,325,114 112,394,349 
Warrants
The Company has issued warrants with varying terms and conditions related to multiple financing rounds, acquisitions and other transactions. The following table summarizes warrant activity for the six months ended June 30, 2020 and the year ended December 31, 2019:
Six Months Ended
June 30, 2020
Year Ended
December 31, 2019
Warrants outstanding, beginning of period38,111,211 3,789,482 
Issued17,000,000 39,199,998 
Exercised— (4,818,269)
Expired(610,000)(60,000)
Warrants outstanding, end of period54,501,211 38,111,211 
As of June 30, 2020 and December 31, 2019, 39,501,211 and 38,111,211 of the outstanding warrants have been recorded and classified as equity. Exercise prices for the outstanding warrants range from $0.37 to $5.38; the weighted average exercise price for the outstanding warrants as of June 30, 2020 is $1.66; and the outstanding warrants expire from 2020 to 2026. See Note 5. Debt for additional information about the outstanding warrants classified as liabilities.